Trial of 3 vaccines in India, most advanced vaccine in third phase

Coronavirus In India cases in India crossed 52 lakhs. According to the Health Ministry on Friday, so far there are 52,14,678 confirmed cases out of which 41,12,552 people have been cured, 84,372 have died and 10,17,754 are active cases. At the same time, the vaccine is waiting eagerly in the country. Three vaccines are currently being tested in the country. One of these vaccines is from Oxford, second is from Bharat Biotech and third is Zydus Cadla.

Talking about the Oxford vaccine, it has been prepared jointly by the pharma company AstraZeneca. One of the most advanced vaccines in the world, this vaccine will be administered by the Serum Institute in India at 14 locations across the country on a trial of one and a half thousand people. Apart from India, the trial of this vaccine is going on in Oxford, UK, USA and Brazil and other countries. The ICMR is monitoring the Oxford vaccine.

With this, together with ICMR and Bharat Biotech, the vaccine is named Covaxin. It is an inactivated vaccine. This means that the corona killed virus is dosed, which produces antibodies against the virus in the body. Recently, it was informed by the company that this vaccine has been successful on animals and currently its second phase trial is going on.